Clinical Overview

Junctional tachycardia is the fastest-rate species of the AV-junctional rhythm genus: a sustained rhythm whose pacemaker sits in the AV junction (the AV node and/or the bundle of His) rather than the sinoatrial (SA) node, running faster than 100 bpm (Hafeez, Wollard, and Grossman, StatPearls, 2026). The same anatomic site produces three recognized rate tiers — junctional escape rhythm (40-60 bpm), accelerated junctional rhythm (60-100 bpm, AJR), and junctional tachycardia (over 100 bpm, JTach) — distinguished from one another by rate alone, not by a different origin (ACLS Certification Association, 2024; Burns and Buttner, LITFL ECG Library, 2024). This dataset’s JTach (Junctional Tachycardia) label names that fastest tier specifically.

Where junctional escape rhythm is a protective failsafe stepping in when the SA node falls silent, junctional tachycardia works in the opposite direction: the AV junction’s own automaticity accelerates past its normal 40-60 bpm intrinsic rate and outpaces a sinus node that is still firing, rather than filling in for one that has stopped (Hafeez, Wollard, and Grossman, StatPearls, 2026; Chun and Jung, Medicine (Baltimore), 2024). Because the tissue simply fires faster on its own rather than being triggered by a re-entrant circuit, onset and offset are typically gradual — a “warm-up” and “cool-down” over several beats — in contrast to the abrupt onset and termination of a reentrant paroxysmal supraventricular tachycardia such as AV nodal reentrant tachycardia (Reid, ECG Lectures, 2025; Chun and Jung, Medicine (Baltimore), 2024). This automatic, gradual-onset form is often called nonparoxysmal (or AV) junctional tachycardia in the literature (Chun and Jung, Medicine (Baltimore), 2024); within this page’s own >100 bpm tachycardia tier specifically, it typically runs 100-180 bpm (ACLS Certification Association, 2024). Because the impulse originates at or near the AV node, it still conducts forward through the normal His-Purkinje system to produce a narrow QRS, but it also conducts backward (retrograde) into the atria rather than through the SA node’s normal top-down path, so the atria depolarize in reverse without producing a normal upright P wave ahead of the QRS (Burns and Buttner, LITFL ECG Library, 2024).

A distinct, more severe entity shares the “junctional tachycardia” name but is not the same clinical picture: junctional ectopic tachycardia (JET) is a rare, much faster (typically 200-250 bpm), predominantly pediatric arrhythmia seen congenitally in infants or in the first 72 hours after congenital heart surgery, and it behaves more aggressively with meaningfully higher risk than the adult nonparoxysmal form described above (Ashraf and Collier, StatPearls, 2025; Wikipedia, “Junctional Ectopic Tachycardia,” citing Haas et al., 2004 and Brugada et al., 2019). This dataset’s JTach-labeled records span typical adult and adolescent ages rather than the neonatal or post-surgical population associated with JET, so they most plausibly reflect the nonparoxysmal form described above rather than pediatric JET.

Clinical significance tracks the underlying cause more than the rhythm itself: adult nonparoxysmal junctional tachycardia is frequently well-tolerated and self-limited once the trigger resolves, but it is also one of the classic ECG findings of digoxin toxicity, and it can mark myocardial ischemia, myocarditis, or recent cardiac surgery (Hafeez, Wollard, and Grossman, StatPearls, 2026; Cleveland Clinic, 2022). Sustained rates toward the upper end of the range, or any occurrence in a hemodynamically fragile patient, can reduce cardiac output enough to cause symptoms (Cleveland Clinic, 2022).

Many patients, especially at more modest rates, have no symptoms and the rhythm is an incidental monitor finding (Cleveland Clinic, 2022). When symptomatic, reported findings include palpitations, dizziness or lightheadedness, fatigue, and syncope or near-syncope (Cleveland Clinic, 2022; Hafeez, Wollard, and Grossman, StatPearls, 2026).

Recognized causes and risk factors include digoxin toxicity — a classic and specifically associated trigger, more likely at a given digoxin level when hypokalemia, hypomagnesemia, or hypercalcemia is also present — myocardial ischemia or infarction, myocarditis, recent cardiac surgery or valve replacement, congenital heart disease, catecholamine or adrenergic excess (including hemorrhagic shock), theophylline, and Lyme disease (Cleveland Clinic, 2022; Hafeez, Wollard, and Grossman, StatPearls, 2026; Regina and Hai, StatPearls, 2025; Chun and Jung, Medicine (Baltimore), 2024; Wikipedia, “Junctional Tachycardia”).

Interpretation Guide

Key Features:

• Rate: over 100 bpm; the nonparoxysmal (automatic) form most often runs roughly 100-180 bpm (ACLS Certification Association, 2024). A junctional-origin rhythm at 60-100 bpm is accelerated junctional rhythm rather than tachycardia, and one at 40-60 bpm is junctional escape rhythm (Burns and Buttner, LITFL ECG Library, 2024).
• Rhythm: regular, aside from the gradual acceleration and deceleration at onset and offset that marks an automatic focus rather than a reentrant one (Reid, ECG Lectures, 2025).
• P waves: absent, or inverted (retrograde) in the inferior leads, appearing just before, buried within, or just after the QRS complex depending on whether retrograde atrial activation or antegrade ventricular activation completes first (ACLS Certification Association, 2024; Hafeez, Wollard, and Grossman, StatPearls, 2026).
• PR interval: short (under 0.12 seconds) when a retrograde P wave precedes the QRS; not measurable when the P wave is buried in or follows the QRS (ACLS Certification Association, 2024).
• QRS complex: narrow, under roughly 0.12 seconds, because the impulse still conducts through the normal His-Purkinje system — unless a pre-existing bundle branch block or rate-related aberrancy is present (ACLS Certification Association, 2024).
• ST segment and T waves are not primary diagnostic features of the junctional origin itself; interpret them against the underlying cause (ischemia, digoxin effect, electrolyte disturbance) rather than the junctional origin.
• QT interval is not a primary diagnostic feature of the junctional origin; assess once a stable strip is captured.
• Other findings: a gradual “warm-up” at onset and “cool-down” at offset over several beats is the most useful bedside clue that a fast junctional rhythm is automatic rather than reentrant (Reid, ECG Lectures, 2025; Chun and Jung, Medicine (Baltimore), 2024). If the SA node is still discharging independently at a similar rate without capturing the ventricle, the atria and the junctional pacemaker can each fire on their own schedule (AV dissociation) rather than in a fixed retrograde 1:1 pattern (Ashraf and Collier, StatPearls, 2025).

Key Leads

• Leads II, III, and aVF — the most useful leads for confirming a retrograde P wave. Retrograde atrial activation travels superiorly, away from these inferior leads, so an inverted P wave here is the most reliable marker of retrograde conduction. This is the same junctional depolarization vector documented across the AV-junctional rate family — the corresponding P wave is typically upright in aVR and V1 (Burns and Buttner, LITFL ECG Library, 2024).
• This condition is not lead-agnostic: the defining P-wave finding is best confirmed in the inferior leads. The narrow QRS and the gradual onset/offset pattern that help establish the rhythm itself, however, can be assessed from any lead with a clear baseline.

Differential Diagnosis

• Accelerated Junctional Rhythm (AJR) — same AV-junctional origin, automatic mechanism, and P-wave behavior, but the rate runs 60-100 bpm rather than over 100 bpm.
• Junctional Escape Rhythm (AVJR) — same anatomic origin and P-wave behavior, but it is a backup mechanism triggered by a failing or absent sinus impulse rather than the junction’s own automaticity accelerating past a still-active sinus node, and it runs at the junction’s intrinsic 40-60 bpm.
• Supraventricular Tachycardia (SVT) — a reentrant paroxysmal SVT such as AV nodal reentrant tachycardia can look similar on a narrow-complex tachycardia strip, but it starts and stops abruptly rather than warming up and cooling down, and it usually runs faster.
• Sinus Tachycardia (ST) — a fast rate can look similar, but sinus tachycardia keeps a normal upright P wave before every QRS with a normal PR interval, versus junctional tachycardia’s absent or retrograde P wave.
• Atrial Tachycardia (AT) — also a fast, sometimes gradually-changing rhythm, but atrial tachycardia’s P wave is present with an abnormal (non-sinus) morphology rather than absent or retrograde.

Treatment Brief

Confirm lead placement and capture a longer strip whenever a fast, narrow-complex rhythm with absent or inverted P waves appears, and correlate the finding with vital signs, symptoms, and current medications — a digoxin level and recent-surgery history are worth flagging for the provider given how strongly this rhythm associates with digoxin toxicity (Cleveland Clinic, 2022; Hafeez, Wollard, and Grossman, StatPearls, 2026).

Because the rhythm is automatic rather than reentrant, it does not reliably terminate with vagal maneuvers, adenosine, or DC cardioversion the way a reentrant SVT does (Ashraf and Collier, StatPearls, 2025). When digoxin toxicity is the underlying cause, cardioversion is specifically avoided because it can precipitate ventricular arrhythmias — defibrillation per standard protocol remains an option if the patient decompensates, but the rhythm itself is not a cardioversion target — so management targets the trigger rather than the rhythm itself (Regina and Hai, StatPearls, 2025; Cleveland Clinic, 2022). Asymptomatic, well-tolerated cases generally need no direct treatment beyond monitoring and investigating the cause. Otherwise, management addresses the underlying trigger directly: holding or adjusting an offending medication, correcting an electrolyte abnormality, reversing digoxin toxicity with digoxin-specific antibody fragments, or treating the ischemia or inflammation driving it, with rate-controlling or antiarrhythmic medication reserved for persistent or poorly-tolerated cases (Cleveland Clinic, 2022; Regina and Hai, StatPearls, 2025; Hafeez, Wollard, and Grossman, StatPearls, 2026).